Jaume Pons
2023
In 2023, Jaume Pons earned a total compensation of $2.7M as President, Chief Scientific Officer and former Chief Executive Officer at ALX ONCOLOGY HOLDINGS, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $357,357 |
|---|---|
| Option Awards | $1,216,689 |
| Salary | $649,740 |
| Stock Awards | $521,540 |
| Total | $2,745,326 |
Pons received $1.2M in option awards, accounting for 44% of the total pay in 2023.
Pons also received $357.4K in non-equity incentive plan, $649.7K in salary and $521.5K in stock awards.
Rankings
In 2023, Jaume Pons' compensation ranked 342nd out of 2,983 executives tracked by ExecPay. In other words, Pons earned more than 88.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 342 out of 2,983 | 89th |
Division Manufacturing | 192 out of 1,637 | 88th |
Major group Chemicals And Allied Products | 131 out of 906 | 86th |
Industry group Drugs | 128 out of 869 | 85th |
Industry Pharmaceutical Preparations | 80 out of 627 | 87th |
Source: SEC filing on April 22, 2024.
Pons' colleagues
We found three more compensation records of executives who worked with Jaume Pons at ALX ONCOLOGY HOLDINGS in 2023.